Skip to main contentAI and Advanced
/
POLYMED · NSEBSE SENSEX74,336.45+0.45%BSE |
NIFTY 5023,217.6+0.43%NSE |
NIFTY BANK56,292.45+0.89%NSE |
NIFTY IT29,087.65-1.58%NSE |
NIFTY AUTO26,893.65+0.51%NSE |
NIFTY FMCG45,559+1.63%NSE |
NIFTY PHARMA26,146.2-0.16%NSE |
NIFTY 50022,532+0.24%NSE |
PO
NSE · Equity shares · Medical Equipment & Supplies0.00 · 0.00%
Poly Medicure POLYMED
NSE:INR 1,704.6
BSE:INR 1,700.7
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for POLYMED
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,704.6
Day rangeINR 1,691.2 — INR 1,716.7
52-week rangeINR 1,182 — INR 2,144.9
Volume1.16 L
Market cap17,256.49
P/E37.47
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,875.26
Net Income (INR Cr)322.14
Rev Growth (5 Year %)18.98
EPS Growth (5 Year %)15.81
P/E Ratio37.47
Book Value263.13
EPS32.25
Price/BV6.48Computed
Research path: Interpret Poly Medicure's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
POLYMEDPoly Medicure1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,918.57 | 3,192.45 | 1,858.67 |
| Cash Equivalents | 36.64 | Not available | Not available |
| Other Liabilities Total | 78.58 | 12.99 | 9.72 |
| Long Term Debt | 52.09 | 0 | 1.09 |
| Common Stock Total | 50.68 | 50.66 | 47.99 |
| Other Current Assets Total | 103.45 | 1.05 | 2.58 |
| Total Assets | 3,918.57 | 3,192.45 | 1,858.67 |
| Current Portof LT Debt/Capital Leases | 296.33 | 4.77 | 20.07 |
| Cash | 51.23 | 8.7 | 12.05 |
| Total Equity | 3,106.17 | 2,765.66 | 1,470.05 |
| Long Term Investments | 34.38 | 20.51 | 28.15 |
| Retained Earnings(Accumulated Deficit) | 3,055.49 | 1,334.9 | 1,025.63 |
| Total Common Shares Outstanding | 10.14 | 10.13 | 9.6 |
| Tangible Book Valueper Share Common Eq | 263.13 | 267.5 | 147.59 |
| Goodwill Net | 273.79 | 28.58 | 28.58 |
| Total Liabilities | 812.39 | 426.79 | 388.62 |
| Total Debt | 353.58 | 180.25 | 174.15 |
| Short Term Investments | 784.66 | 1,201.53 | 280.28 |
| Cashand Short Term Investments | 872.53 | 1,210.22 | 292.33 |
| Total Receivables Net | 531.92 | 416.63 | 322.52 |
| Deferred Income Tax | 57.97 | 42.87 | 24.48 |
| Accounts Receivable-Trade Net | 531.17 | 353.96 | 274.26 |
| Property/Plant/Equipment Total-Net | 1,353.62 | 1,130.2 | 888.94 |
| Minority Interest | 43.07 | Not available | Not available |
| Total Current Liabilities | 575.52 | 370.17 | 351.24 |
| Total Inventory | 433.84 | 285.57 | 221.03 |
| Accounts Payable | 122.67 | 86.42 | 95.6 |
| Other Currentliabilities Total | 156.53 | 59.93 | 84.54 |
| Total Long Term Debt | 57.25 | 0.77 | 3.18 |
| Intangibles Net | 165.3 | 26.61 | 24.99 |
| Other Long Term Assets Total | 149.75 | 20.59 | 13.82 |
| Total Current Assets | 1,941.73 | 1,917 | 841.63 |
| Capital Lease Obligations | 5.16 | 0.77 | 2.09 |
| Accumulated Depreciation Total | Not available | -486.12 | -421.34 |
| Accrued Expenses | Not available | 44.35 | 0.12 |
| Other Equity Total | Not available | 1.76 | 3.11 |
| Prepaid Expenses | Not available | 3.52 | 3.16 |
| Additional Paid-In Capital | Not available | 1,378.34 | 393.33 |
| Property/Plant/Equipment Total-Gross | Not available | 1,526.67 | 1,243.58 |
| Notes Payable/Short Term Debt | Not available | 174.7 | 150.91 |
| Note Receivable-Long Term | Not available | 48.96 | 32.56 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio2.78
Price to Sale Ratio9.20
Growth
Debt 5Yr CAGR %20.8
Margins
Operating Margin 12m17.09
Operating Margin 5y Avg19.51
Net Profit Margin 12m17.1
Net Profit Margin 5y17.87
Yield
Dividend Yield %0.2
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk46.91
Analyst consensus
ConsensusHold
Consensus score2.60
Analyst opinions5
Strong Sell count0
Sell count1
Hold count2
Buy count1
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Lenskart Solutions | INR 565.7 | 98,565.99 | 181 | — |
| Laxmi Dental | INR 216.7 | 1,197.04 | 35.63 | — |
| Mallcom (India) | INR 1,022 | 637.72 | 21.91 | — |
| One Global Service Provider | INR 567 | 1,108.09 | 16.95 | — |
| Hemant Surgical Industries | INR 365 | 530.62 | 26.04 | — |
Shareholding
Ownership
- Promoter
- 62.42%
- FII
- 5.56%
- MF
- 9.61%
- Other
- 22.41%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Poly Medicure Investing In Facilities And Products To Double International Sales - SahiMarket news · 17 Jul 2026, 9:30 am
Poly Medicure Investing In Facilities And Products To Double International Sales Sahi
Poly Medicure bets on new facilities, products to double international business: MD - The Economic TimesMarket news · 17 Jul 2026, 1:08 am
Poly Medicure bets on new facilities, products to double international business: MD The Economic Times
Delhi HC stays stamp duty order against Poly Medicure - scanx.tradeMarket news · 8 Jul 2026, 12:55 pm
Delhi HC stays stamp duty order against Poly Medicure scanx.trade
Poly Medicure among 4 stocks that closed below VWAP - The Economic TimesMarket news · 6 Jul 2026, 11:17 am
Poly Medicure among 4 stocks that closed below VWAP The Economic Times
Poly Medicure - Positive Breakout: These 8 stocks cross above their 200 DMAs - The Economic TimesMarket news · 30 Jun 2026, 12:30 pm
Poly Medicure - Positive Breakout: These 8 stocks cross above their 200 DMAs The Economic Times
Poly Medicure Targets 20% Domestic Growth and 16% International Revenue Hike in FY26 - SahiMarket news · 30 Jun 2026, 11:53 am
Poly Medicure Targets 20% Domestic Growth and 16% International Revenue Hike in FY26 Sahi
Corporate actions
Events
- board MeetingsQuarterly Results
- dividendRs.3.5000 per share(70%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.3.5000 per share(70%)Final Dividend
- board MeetingsTo consider other business matters.
Rusaka Markets Community
Discussion and sentiment for Poly Medicure
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
Company facts
- Industry
- Medical Equipment & Supplies
- Sector
- Medical Equipment & Supplies
- NSE Code
- POLYMED
- BSE Code
- 531768
Questions
Stock FAQ
What is the symbol and ISIN of Poly Medicure?
Poly Medicure has the symbol POLYMED and ISIN - INE205C01021.
What is the current price of Poly Medicure?
Poly Medicure is currently trading at INR 1,704.60.
What are the year high and year low of Poly Medicure?
Poly Medicure has a year high of INR 2,144.90 and a year low of INR 1,182.00.
What is the market capitalization of Poly Medicure?
Poly Medicure has a market capitalization of INR 17,256.49 crore.
What is the P/E ratio of Poly Medicure?
Poly Medicure has a P/E ratio of 37.47.
What is the dividend yield of Poly Medicure?
Poly Medicure has a dividend yield of 0.20%.
How is the financial performance of Poly Medicure based on revenue, net income, and EPS?
Poly Medicure has revenue of INR 1,875.26 crore, net income of INR 322.14 crore, and EPS of INR 32.24.
What is the book value of Poly Medicure?
Poly Medicure has a book value of INR 263.13.
What is the debt-to-equity ratio of Poly Medicure?
Poly Medicure has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Poly Medicure?
Poly Medicure has a price-to-book ratio of 6.48 and a price-to-sales ratio of 9.20.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.